MyFinsight
Home
Blog
About
Short term
investments
$191,566K
Cash and cash
equivalents
$72,334K
(-70.34%↓ Y/Y)
Other current assets
$6,334K
(-85.24%↓ Y/Y)
Prepaid assets
$4,506K
(-71.80%↓ Y/Y)
Restricted cash, current
portion
$311K
Total current assets
$275,051K
(-78.01%↓ Y/Y)
Property and equipment,
net
$4,066K
(-80.20%↓ Y/Y)
Right-of-use asset
$1,289K
(-69.51%↓ Y/Y)
Restricted cash, net of
current portion
$106K
(-96.21%↓ Y/Y)
Total assets
$280,512K
(-79.51%↓ Y/Y)
Total liabilities and
stockholders' equity / former...
$280,512K
(-79.51%↓ Y/Y)
Total stockholders'
equity / former...
$214,576K
(-82.01%↓ Y/Y)
Total liabilities
$65,936K
(-62.59%↓ Y/Y)
Accumulated deficit
-$8,058K
(99.31%↑ Y/Y)
Accumulated other
comprehensive loss, net
-$235K
(-113.22%↓ Y/Y)
Additional paid-in capital
$222,853K
(-90.55%↓ Y/Y)
Deferred revenue, net of
current portion
$33,653K
(-15.85%↓ Y/Y)
Total current
liabilities
$31,508K
(-76.67%↓ Y/Y)
Other long-term
liabilities
$775K
Common stock, 0.001 par
value 400,000 shares...
$16K
(33.33%↑ Y/Y)
Accrued liabilities
$13,312K
Deferred revenue,
current portion
$9,038K
(-33.23%↓ Y/Y)
Accrued compensation
$3,962K
(-78.52%↓ Y/Y)
Accounts payable
$3,513K
(-10.25%↓ Y/Y)
Lease liabilities
$1,683K
(-57.12%↓ Y/Y)
Back
Back
Balance Sheet
Atrium Therapeutics, Inc. (RNA)
Atrium Therapeutics, Inc. (RNA)
source: myfinsight.com